We recommend to visit
Summary
Introduction. Antinuclear antibodies are used in diagnostics of rheumatic diseases. By indirect immunofluorescence dense fine speckled fluorescence pattern can be detected, which is associated with anti- DFS70 antibodies. It is thought that anti- DFS70 antibodies can be a useful biomarker to rule out rheumatic diseases. The aim of this study was to investigate the prevalence of anti-DFS70 antibodies and their association with other antinuclear antibodies in patients with rheumatic diseases.
EN
